TRT on TikTok: separating real hormone science from bro-science

What did @trtsgtmaj2 actually say?

The creator shared a viewer's comment describing a journey that started at age 27, with a total testosterone of 191 ng/dL, and after two months of TRT, climbing to 1,113 ng/dL. The creator called 191 "insanely low" and reported the viewer's red blood cell count, hemoglobin, and hematocrit were "still in perfect range." They also listed classic low-T symptoms, including low libido, increased body fat, muscle loss, irritability, and poor sleep, and invited followers to comment for help starting their own TRT journey.

The framing is testimonial-first, which is worth flagging. One person's two-month snapshot is not a clinical outcome. The creator is not identified as a physician, and the call to action, "comment TRT, I'll send you information," operates more like a referral pipeline than medical guidance.

Does the science back this up?

On the core numbers, yes, largely. A total testosterone of 191 ng/dL in a 27-year-old male is clinically low by any major guideline's definition, and the symptom list the creator rattles off maps reasonably well to established hypogonadism criteria.

The American Urological Association defines hypogonadism as total testosterone below 300 ng/dL with associated symptoms (Mulhall et al., 2018, Journal of Urology). The Endocrine Society sets a similar threshold and requires two morning measurements before diagnosis (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). A 191 ng/dL reading would meet the numerical threshold, but the creator never mentions whether this was a single fasting morning draw or confirmed with a repeat test. That matters clinically.

The symptom list, including low libido, poor sleep, increased fat mass, and irritability, has solid mechanistic support. Testosterone plays a documented role in mood regulation, body composition, and sleep architecture (Leproult and Van Cauter, 2011, JAMA).

What did they get wrong (or right)?

Let's be honest about what the creator got right first. Calling 191 ng/dL "insanely low" for a 27-year-old is not an exaggeration. Reference ranges for young adult males typically run 400 to 900 ng/dL, sometimes higher depending on the lab. The symptom list is accurate and non-sensationalized. Giving credit where it is due: that part is fine.

What's more problematic is the landing point of 1,113 ng/dL after two months. That's above the upper limit of the normal reference range for most labs, which cap around 900 to 1,000 ng/dL. The creator frames this as purely positive, but supraphysiologic testosterone levels come with real monitoring obligations, including hematocrit rises, cardiovascular considerations, and SHBG shifts. The creator does mention hematocrit is "in perfect range," which is the right thing to be watching, but presents it as a reassuring footnote rather than an ongoing clinical concern.

The creator also never mentions that hypogonadism in a 27-year-old requires workup to find the cause. Secondary hypogonadism from pituitary dysfunction, primary testicular failure, obesity, sleep apnea, or medication use are all possibilities that should be ruled out before starting exogenous testosterone (Bhasin et al., 2018).

What should you actually know?

If you're a young man with symptoms and a low testosterone reading, the creator is right that you should get evaluated. But "comment TRT" is not a substitute for a proper workup. Here is what the clinical process should actually look like.

• Two fasting morning testosterone measurements, not one, are required for diagnosis under Endocrine Society guidelines.
• LH and FSH levels should be checked to determine whether hypogonadism is primary or secondary. This changes the treatment approach entirely.
• A post-treatment testosterone of 1,113 ng/dL sits above most clinical targets. Most guidelines aim for mid-normal range, roughly 400 to 700 ng/dL, not supraphysiologic levels.
• Hematocrit should be monitored at 3 and 6 months, then annually. Elevated hematocrit from TRT increases thrombotic risk (Xu et al., 2013, BMJ).
• Fertility implications matter in a 27-year-old. Exogenous testosterone suppresses LH and FSH, which shuts down sperm production. This should be part of the conversation before starting treatment.

The creator is selling urgency, "that could be you and it should be you." That framing pushes people toward action before they have the diagnostic information they actually need to make an informed decision.